Taiwan · Delayed Price · Currency is TWD TLC BioSciences Statistics
Total Valuation
TLC BioSciences has a market cap or net worth of TWD 58.57 billion. The enterprise value is 57.81 billion.
| Market Cap | 58.57B |
| Enterprise Value | 57.81B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TLC BioSciences has 133.56 million shares outstanding.
| Current Share Class | 133.56M |
| Shares Outstanding | 133.56M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +21.22% |
| Owned by Insiders (%) | 24.53% |
| Owned by Institutions (%) | n/a |
| Float | 88.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 746.65 |
| PB Ratio | 35.14 |
| P/TBV Ratio | 35.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.17, with a Debt / Equity ratio of 0.49.
| Current Ratio | 2.17 |
| Quick Ratio | 1.67 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.85 |
| Interest Coverage | -13.15 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -98.09% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TLC BioSciences has paid 4.66 million in taxes.
| Income Tax | 4.66M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 264.17 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 74.52 |
| Average Volume (20 Days) | 586,978 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TLC BioSciences had revenue of TWD 78.44 million and -1.82 billion in losses. Loss per share was -18.95.
| Revenue | 78.44M |
| Gross Profit | 48.62M |
| Operating Income | -1.72B |
| Pretax Income | -1.82B |
| Net Income | -1.82B |
| EBITDA | -1.65B |
| EBIT | -1.72B |
| Loss Per Share | -18.95 |
Balance Sheet
The company has 1.58 billion in cash and 816.73 million in debt, with a net cash position of 758.48 million or 5.68 per share.
| Cash & Cash Equivalents | 1.58B |
| Total Debt | 816.73M |
| Net Cash | 758.48M |
| Net Cash Per Share | 5.68 |
| Equity (Book Value) | 1.67B |
| Book Value Per Share | 12.48 |
| Working Capital | 1.11B |
Cash Flow
In the last 12 months, operating cash flow was -877.45 million and capital expenditures -85.03 million, giving a free cash flow of -962.49 million.
| Operating Cash Flow | -877.45M |
| Capital Expenditures | -85.03M |
| Depreciation & Amortization | 67.18M |
| Net Borrowing | -34.74M |
| Free Cash Flow | -962.49M |
| FCF Per Share | -7.21 |
Margins
| Gross Margin | 61.99% |
| Operating Margin | -2,192.34% |
| Pretax Margin | -2,315.16% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TLC BioSciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -3.11% |
| FCF Yield | -1.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TLC BioSciences has an Altman Z-Score of 6.79 and a Piotroski F-Score of 1.
| Altman Z-Score | 6.79 |
| Piotroski F-Score | 1 |